Universal Beteiligungs und Servicegesellschaft mbH Increases Position in Stryker Corporation $SYK

Universal Beteiligungs und Servicegesellschaft mbH lifted its position in shares of Stryker Corporation (NYSE:SYK) by 4.5% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 448,358 shares of the medical technology company’s stock after buying an additional 19,138 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Stryker were worth $158,012,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Clayton Financial Group LLC purchased a new position in shares of Stryker during the third quarter valued at approximately $26,000. United Financial Planning Group LLC purchased a new position in shares of Stryker during the third quarter valued at approximately $27,000. Strive Asset Management LLC purchased a new position in shares of Stryker during the third quarter valued at approximately $30,000. ANTIPODES PARTNERS Ltd purchased a new position in shares of Stryker during the third quarter valued at approximately $34,000. Finally, Copia Wealth Management lifted its stake in shares of Stryker by 181.6% during the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock valued at $40,000 after buying an additional 69 shares during the period. Hedge funds and other institutional investors own 77.09% of the company’s stock.

Insider Activity

In other news, Director Ronda E. Stryker sold 250,000 shares of the stock in a transaction on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the completion of the sale, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. This represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 4.60% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts recently issued reports on the stock. Jefferies Financial Group reissued a “buy” rating and set a $465.00 price objective on shares of Stryker in a research note on Wednesday, March 4th. TD Cowen downgraded shares of Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target on the stock. in a research note on Monday, January 26th. Truist Financial cut their price target on shares of Stryker from $395.00 to $380.00 and set a “hold” rating on the stock in a research note on Wednesday, April 15th. Needham & Company LLC increased their price target on shares of Stryker from $448.00 to $454.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Finally, The Goldman Sachs Group cut their price target on shares of Stryker from $403.00 to $357.00 and set a “neutral” rating on the stock in a research note on Thursday, April 9th. Fifteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $421.11.

Stryker Stock Performance

NYSE:SYK opened at $327.63 on Wednesday. Stryker Corporation has a fifty-two week low of $319.32 and a fifty-two week high of $404.87. The firm’s 50 day moving average is $351.94 and its two-hundred day moving average is $359.01. The company has a market cap of $125.48 billion, a P/E ratio of 39.00, a P/E/G ratio of 1.98 and a beta of 0.92. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.40 by $0.07. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The company had revenue of $7.17 billion during the quarter, compared to analyst estimates of $7.12 billion. During the same quarter in the prior year, the business earned $4.01 earnings per share. The business’s quarterly revenue was up 11.4% compared to the same quarter last year. Analysts expect that Stryker Corporation will post 14.92 EPS for the current year.

Stryker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be given a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. Stryker’s dividend payout ratio is presently 41.90%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.